How do chemically defended animals resist their own toxins? This intriguing question on the concept of autotoxicity is at the heart of how species interactions evolve. In this issue of Molecular Ecology (Molecular Ecology, 2024, 33), Bodawatta and colleagues report on how Papua New Guinean birds coopted deadly neurotoxins to create lethal mantles that protect against predators and parasites. Combining chemical screening of the plumage of a diverse collection of passerine birds with genome sequencing, the researchers unlocked a deeper understanding of how some birds sequester deadly batrachotoxin (BTX) from their food without poisoning themselves. They identified that birds impervious to BTX bear amino acid substitutions in the toxin-binding site of the voltage-gated sodium channel Nav1.4, whose function is essential for proper contraction and relaxation of vertebrate muscles. Comparative genetic and molecular docking analyses show that several of the substitutions associated with insensitivity to BTX may have become prevalent among toxic birds through positive selection. Intriguingly, poison dart frogs that also co-opted BTX in their lethal mantles were found to harbour similar toxin insensitivity substitutions in their Nav1.4 channels. Taken together, this sets up a powerful model system for studying the mechanisms behind convergent molecular evolution and how it may drive biological diversity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11068370PMC
http://dx.doi.org/10.1111/mec.17358DOI Listing

Publication Analysis

Top Keywords

lethal mantles
12
poison dart
8
dart frogs
8
molecular ecology
8
birds
6
toxic touch
4
touch makings
4
makings lethal
4
mantles pitohui
4
pitohui birds
4

Similar Publications

Article Synopsis
  • Venetoclax (VEN) shows promising activity against various lymphomas and leukemias, but remissions tend to be short, prompting the need for combination therapies.
  • Research found that combining VEN with A1155463, a BCL-XL inhibitor, created a strong synergistic effect and could overcome resistance in certain cell lines, even those lacking BCL2L11/BIM, which is often linked to VEN resistance.
  • In vivo studies confirmed the effectiveness of this combination in multiple patient-derived models, and a unique treatment schedule of 4 days on/3 days off minimized side effects, making this a potential innovative approach for treating BCL2+ hematologic malignancies.
View Article and Find Full Text PDF

How do chemically defended animals resist their own toxins? This intriguing question on the concept of autotoxicity is at the heart of how species interactions evolve. In this issue of Molecular Ecology (Molecular Ecology, 2024, 33), Bodawatta and colleagues report on how Papua New Guinean birds coopted deadly neurotoxins to create lethal mantles that protect against predators and parasites. Combining chemical screening of the plumage of a diverse collection of passerine birds with genome sequencing, the researchers unlocked a deeper understanding of how some birds sequester deadly batrachotoxin (BTX) from their food without poisoning themselves.

View Article and Find Full Text PDF
Article Synopsis
  • Mantle cell lymphoma (MCL) is a cancer characterized by uncontrolled cell growth, and researchers studied how well palbociclib, a CDK 4/6 inhibitor, works alone and with venetoclax, a BCL2 inhibitor, on MCL cells.
  • They conducted experiments using both MCL cell lines and patient-derived models to evaluate the effectiveness, mechanisms, and potential markers that could indicate which patients might benefit from this combination therapy.
  • The findings showed that the combination treatment was more effective than either drug alone, particularly for patients with MCL that does not have RB1 deletion, suggesting a promising approach to treating this type of lymphoma without traditional chemotherapy.
View Article and Find Full Text PDF

Proteasome inhibitor bortezomib is an anticancer agent approved for treatment of multiple myeloma and mantle cell lymphoma. However, its application in other types of cancer, primarily in solid tumors, is limited due to poor pharmacokinetics, inefficient tissue penetration, low stability and frequent adverse effects. In the present study, a novel micellar nano-scaled delivery system was manufactured, composed of amphiphilic poly(N-vinylpyrrolidone) nanoparticles loaded with bortezomib.

View Article and Find Full Text PDF

Bruton's tyrosine kinase inhibitors (BTKi) and CAR T-cell therapy have demonstrated tremendous clinical benefits in mantle cell lymphoma (MCL) patients, but intrinsic or acquired resistance inevitably develops. In this study, we assessed the efficacy of the highly potent and selective MCL-1 inhibitor AZD5991 in various therapy-resistant MCL cell models. AZD5991 markedly induced apoptosis in these cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!